About Ista Pharmaceuticals (NASDAQ:ISTA)
ISTA Pharmaceuticals, Inc. (ISTA) is a commercial-stage, multi-specialty pharmaceutical company. The Company is engaged in developing, marketing and selling its own products in the United States and Puerto Rico. ISTA is a prescription eye care business in the United States and has an allergy drug franchise. ISTA manufactures its finished good products through third-party contracts. ISTA in-licenses or acquires new products and technologies to add to its internal development. Its products and product candidates seek to treat allergy and diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye and ocular and nasal allergies. It has four products available for sale in the United States and Puerto Rico: BROMDAY (bromfenac ophthalmic solution) 0.09%, BEPREVE (bepotastine besilate ophthalmic solution) 1.5%, ISTALOL (timolol maleate ophthalmic solution) 0.5% and VITRASE (hyaluronidase injection).
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Ista Pharmaceuticals (NASDAQ:ISTA) Frequently Asked Questions
What is Ista Pharmaceuticals' stock symbol?
Ista Pharmaceuticals trades on the NASDAQ under the ticker symbol "ISTA."
Who are some of Ista Pharmaceuticals' key competitors?
Some companies that are related to Ista Pharmaceuticals include Roche (ROG), Sanofi (SAN), Bayer (BAYN), CSL (CSL), GlaxoSmithKline (GSK), AstraZeneca (AZN), Covidien (COV), Beximco Pharmaceuticals (BXP), Shire (SHP), Essilor International (EI), C R Bard (BCR), Medivation (MDVN), Ramsay Health Care (RHC), CareFusion (CFN), AEGON (AGN), Bioverativ (BIVV), Cochlear (COH) and Salix Pharmaceuticals (SLXP).
Has Ista Pharmaceuticals been receiving favorable news coverage?
Media coverage about ISTA stock has trended positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Ista Pharmaceuticals earned a news impact score of 0.39 on Accern's scale. They also assigned news coverage about the specialty pharmaceutical company an impact score of 45.19 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of Ista Pharmaceuticals?
Shares of ISTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Ista Pharmaceuticals?
Ista Pharmaceuticals' mailing address is #D1, 10574 Acacia Street, RANCHO CUCAMONGA, CA 91730, United States. The specialty pharmaceutical company can be reached via phone at +1-949-7886000.
MarketBeat Community Rating for Ista Pharmaceuticals (ISTA)MarketBeat's community ratings are surveys of what our community members think about Ista Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Ista Pharmaceuticals (NASDAQ:ISTA) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Ista Pharmaceuticals (NASDAQ:ISTA) Earnings History and Estimates Chart
Ista Pharmaceuticals (NASDAQ ISTA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Ista Pharmaceuticals (NASDAQ:ISTA) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Ista Pharmaceuticals (NASDAQ:ISTA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Ista Pharmaceuticals (NASDAQ ISTA)
No insider trades for this company have been tracked by MarketBeat.com
Ista Pharmaceuticals (NASDAQ ISTA) News Headlines
Ista Pharmaceuticals (NASDAQ:ISTA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Ista Pharmaceuticals (NASDAQ:ISTA) Income Statement, Balance Sheet and Cash Flow Statement
Ista Pharmaceuticals (NASDAQ ISTA) Stock Chart for Wednesday, March, 21, 2018